Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer
Leiming Wang, Mafei Xu, Jun Qin, et al.
Oncotarget (2016) Vol. 7, Iss. 12, pp. 14673-14683
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier
Joséphine Zangari, Francesco Petrelli, Benoît Maillot, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1068-1068
Open Access | Times Cited: 106
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 87
The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism
Nicole K.H. Yiew, Brian N. Finck
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 1, pp. E33-E52
Open Access | Times Cited: 38
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
Xiaoli Li, Gaoyang Han, Xiaoran Li, et al.
Oncotarget (2017) Vol. 8, Iss. 28, pp. 46363-46380
Open Access | Times Cited: 62
Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1
Leiming Wang, Mafei Xu, Chung‐Yang Kao, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 4, pp. 1782-1792
Open Access | Times Cited: 60
COUP-TFII in Health and Disease
S. Polvani, Sara Pepe, Stefano Milani, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 101-101
Open Access | Times Cited: 57
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ainhoa Ruiz-Iglesias, Santos Mañes
Cancers (2021) Vol. 13, Iss. 7, pp. 1488-1488
Open Access | Times Cited: 51
The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions
Chaoran Jia, Yulun Wu, Gao Feng, et al.
Free Radical Biology and Medicine (2024) Vol. 214, pp. 2-18
Closed Access | Times Cited: 6
Membrane transporters in cell physiology, cancer metabolism and drug response
Sara Alam, Emily Doherty, Paula Ortega-Prieto, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 11
Open Access | Times Cited: 15
MPC1-like Is a Placental Mammal-specific Mitochondrial Pyruvate Carrier Subunit Expressed in Postmeiotic Male Germ Cells
Benoît Vanderperre, Kristina Cermakova, Jessica Escoffier, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 32, pp. 16448-16461
Open Access | Times Cited: 42
SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB
Guiqin Song, Kang Liu, Xiaolin Yang, et al.
Oncotarget (2017) Vol. 8, Iss. 11, pp. 17771-17784
Open Access | Times Cited: 42
Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance
Yuji Takaoka, Masamitsu Konno, Jun Koseki, et al.
Cancer Science (2019) Vol. 110, Iss. 4, pp. 1331-1339
Open Access | Times Cited: 42
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
Chia‐Lin Chen, Ching‐Yu Lin, Hsing‐Jien Kung
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13435-13435
Open Access | Times Cited: 32
Mitochondrial pyruvate carrier 1: a novel prognostic biomarker that predicts favourable patient survival in cancer
Chen Xue, Ganglei Li, Zhengyi Bao, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer
Mengfei Yao, Xingming Zhang, Tianqi Wu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Ochratoxin A-induced mitochondrial pathway apoptosis and ferroptosis by promoting glycolysis
Yao Zhou, Wen‐Ying Chen, Shiyu Feng, et al.
APOPTOSIS (2025)
Closed Access
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
Xiaoli Li, Yasai Ji, Gaoyang Han, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 36
Stem Cell Metabolism in Cancer and Healthy Tissues: Pyruvate in the Limelight
Cyril Corbet
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 34
MPC1 is essential for PGC-1α-induced mitochondrial respiration and biogenesis
Eunjin Koh, Young Kyung Kim, Daye Shin, et al.
Biochemical Journal (2018) Vol. 475, Iss. 10, pp. 1687-1699
Closed Access | Times Cited: 32
Mitochondrial pyruvate carrier 1 functions as a tumor suppressor and predicts the prognosis of human renal cell carcinoma
Xiaopeng Tang, Qian Chen, Yi Li, et al.
Laboratory Investigation (2018) Vol. 99, Iss. 2, pp. 191-199
Open Access | Times Cited: 32
Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction
Lalita Oonthonpan, Adam J. Rauckhorst, Lawrence R. Gray, et al.
JCI Insight (2019) Vol. 4, Iss. 13
Open Access | Times Cited: 32
MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway
Hongbo Zou, Qian Chen, Anmei Zhang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 31
Oncogenic KRAS signaling activates mTORC1 through COUP‐TFII‐mediated lactate production
Jun‐Kyu Byun, Mihyang Park, Jae Won Yun, et al.
EMBO Reports (2019) Vol. 20, Iss. 6
Open Access | Times Cited: 31
Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer
Jianfu Zhou, Yuliang Wang, Dinglan Wu, et al.
Oncogene (2021) Vol. 40, Iss. 15, pp. 2625-2634
Open Access | Times Cited: 25
Inactivation of mitochondrial pyruvate carrier promotes NLRP3 inflammasome activation and gout development via metabolic reprogramming
Lih‐Chyang Chen, Yu‐Jen Chen, Hsin‐An Lin, et al.
Immunology (2023) Vol. 169, Iss. 3, pp. 271-291
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top